Ingredient record · Diabetes medicine (sulfonylurea)
Glipizide: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
2 entries containing Glipizide are on India's banned-drugs list, and 1 is banned today. 8 batches of medicines containing Glipizide failed a government lab test between June 2023 and July 2026, from 6 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
On the banned-drugs list
Glipizide on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Glipizide2.5mg + Metformin 400mgFixed-dose combination · diabetes | Banned | S.O. 4480(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Glipizide 2.5mg + Metformin 400mgFixed-dose combination · diabetes | Quashed | S.O. 816(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Glipizide | 4 | 4 | Jul 2026 |
| Glipizide Metformin | 3 | 3 | Dec 2025 |
| Glipizideand Metformin | 1 | 1 | May 2024 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Glipizide Tablets IP | SPA252473Mfg 2025-11 · Exp 2027-10 | Skymap Pharmaceuticals Pvt. LtdUttarakhand | Does not conform to IP Standards with respect to Dissolution TestDissolution | Food & Drugs Laboratory Bambolim, GoaState lab | Jul 2026 |
| Glipizide Tablets IP 5 mg | TCY24030ALMfg 2024-12 · Exp 2026-11 | Hindustan Laboratories LimitedMaharashtra | DescriptionDescription | DTL, Madurai-19State lab | Feb 2026 |
| Glipizide and Metformin Tablets USP | URDT0328Mfg 2023-01 · Exp 2025-12 | Unicure India LtdUttarakhand | The sample does not conform to the IP with respect to Dissolution of Glipizide.Dissolution | DTL UdaipurState lab | Dec 2025 |
| Glipizide & Metformin Tablets I.P | Z24-011Mfg 2024-01 · Exp 2026-12 | Zee Laboratories LtdHimachal Pradesh | DescriptionDescription | CDTL IndoreCDSCO lab | Jun 2025 |
| Glipizide Tablets I.P. 5 mg | Z24-187Mfg 2024-02 · Exp 2026-01 | Zee Laboratories LtdHimachal Pradesh | DissolutionDissolution | CDL KolkataCDSCO lab | Sep 2024 |
| Glipizide and Metformin Tablets IP (Glynase-MF) | 4010026Mfg 2023-11 · Exp 2025-04 | USV Private LimitedKarnataka | Dissolution of GlipizideDissolution | CDL KolkataCDSCO lab | Jun 2024 |
| GLIPIZIDEAND METFORMIN TABLETS IP | 4010026Mfg 2023-11 · Exp 2025-04 | USV Private LimitedKarnataka | The sample does not conform to claim I.P. with respect to the test for Dissolution of GlipizideDissolution | CDL KolkataCDSCO lab | May 2024 |
| Glipizide Tablets I.P. 5 mg | T3180Mfg 2023-03 · Exp 2025-02 | Stallion Laboratories Pvt. LtdGujarat | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2023 |
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.